
Unifying Clinical Trial Systems Without Study Disruption: A Practical, Phased Approach
A Practical, Phased Approach to Technology Consolidation
HomeSponsor & CRO Success Stra...

A Practical, Phased Approach to Technology Consolidation

Focus In: Strategies for Clinical Research Associates Clinical trials rarely fall off track because of one major issue. Sometimes a document is filed late, or a query lingers longer than expected. A process can look compliant on paper and then go awry in practice. And much like a plane that’s a few degrees off course, the deviation may seem minor

Portfolio reviews are meant to provide clarity. They are designed to give sponsors a clear, shared understanding of how their clinical trials are progressing, where risks are emerging, and what decisions need to be made next. At their best, portfolio reviews align leadership, clinical operations, and data teams around a common picture of reality. But for many sponsors, portfolio reviews

In many sponsor organizations, Electronic Data Capture (EDC), electronic Trial Master File (eTMF), and Clinical Trial Management Systems (CTMS) are treated as distinct operational domains. Each system has its own purpose, its own workflows, and its own users. On paper, this separation can appear logical—even reassuring. Best‑in‑class tools are selected for each function, teams are trained accordingly, and responsibilities are

Sponsors lose trust in their trial data gradually, not all at once. Trust erodes slowly, often quietly, as small mismatches, delays, and workarounds accumulate across the life of a study. By the time trust is openly questioned, the underlying causes have usually been in place for months—or even years. Why Do Sponsors Lose Trust? This loss of confidence is rarely